Champions Oncology Liabilities 2024

Champions Oncology Aktienanalyse

What does Champions Oncology do?

Champions Oncology Inc is an American company specialized in the development of personalized cancer therapies. It was founded in 2009 by Dr. Ronnie Morris and Joel Ackerman and is headquartered in Hackensack, New Jersey. The history of Champions Oncology began with Dr. Morris' previous work on the development of personalized cancer therapies. He wanted to improve the conventional, often ineffective method of chemotherapy by directly extracting and analyzing tumor cells from patients. Based on these analyses, a therapy tailored to each patient should then be developed. The idea of personalized cancer therapies was born and subsequently led to the founding of Champions Oncology. The business model of Champions Oncology consists of offering personalized solutions for the treatment of cancer to patients, doctors, and pharmaceutical companies. The company has three main divisions: patient services, translational services, and preclinical services. In the patient services division, Champions Oncology offers cancer patients the opportunity to receive personalized cancer therapies. For this purpose, a tumor sample is directly taken from the patient, analyzed, and a therapy tailored to the patient is developed based on the analysis. Patients can thus receive a treatment specifically tailored to them, potentially increasing their chances of recovery. The translational services division of Champions Oncology is focused on supporting pharmaceutical companies in the development of personalized anti-cancer drugs. For this purpose, Champions Oncology offers its platform, which allows tumor cells from patients to be cultured in a controlled environment and tested for their effectiveness against specific types of cancer. This way, pharmaceutical companies can test potential new drugs without having to conduct expensive and time-consuming clinical trials. The preclinical services division of Champions Oncology offers pharmaceutical companies preclinical studies on cancer therapies that are specifically tailored to their needs. For this purpose, the company has a broad portfolio of tumor models for various types of cancer that can be used for the development and validation of new therapies. Champions Oncology offers several products and services, all focused on the development of personalized cancer therapies. These include: - TumorGraft: This is a platform for the cultivation of tumor cells directly isolated from patient samples. The platform allows for testing the effectiveness of cancer therapies directly on a patient sample. - TumorImmune: This platform combines the TumorGraft technology with specific immune modulators to measure the interaction between the patient's immune system and the tumor. The platform aims to help identify therapeutic targets for new cancer treatments. - TumorEscape: This platform allows for the analysis of tumor cells' resistance to chemotherapy and other cancer treatments. This can help identify new targets for cancer treatment and improve the effectiveness of existing therapies. Overall, Champions Oncology is an innovative and promising company specializing in the development of personalized cancer therapies. With its unique platform technology and tailored services, it is well-positioned to meet the growing demand for personalized cancer therapies. Champions Oncology ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Champions Oncology's Liabilities

Champions Oncology's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Champions Oncology's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Champions Oncology's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Champions Oncology's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Champions Oncology’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Champions Oncology stock

What is the level of liabilities of Champions Oncology this year?

Champions Oncology has a debt balance of 28.03 M USD this year.

What were the liabilities of Champions Oncology compared to the previous year?

The liabilities of Champions Oncology have increased by 6.68% increased compared to the previous year.

What are the consequences of high debt for investors of Champions Oncology?

High liabilities can pose a risk for investors of Champions Oncology, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Champions Oncology?

Low liabilities mean that Champions Oncology has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Champions Oncology affect the company?

An increase in liabilities of Champions Oncology can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Champions Oncology affect the company?

A decrease in the liabilities of Champions Oncology can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Champions Oncology?

Some factors that can influence the liabilities of Champions Oncology include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Champions Oncology so important for investors?

The liabilities of Champions Oncology are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Champions Oncology take to modify the liabilities?

To change its liabilities, Champions Oncology can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Champions Oncology pay?

Over the past 12 months, Champions Oncology paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Champions Oncology is expected to pay a dividend of 0 USD.

What is the dividend yield of Champions Oncology?

The current dividend yield of Champions Oncology is .

When does Champions Oncology pay dividends?

Champions Oncology pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Champions Oncology?

Champions Oncology paid dividends every year for the past 0 years.

What is the dividend of Champions Oncology?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Champions Oncology located?

Champions Oncology is assigned to the 'Health' sector.

Wann musste ich die Aktien von Champions Oncology kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Champions Oncology from 9/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Champions Oncology pay the last dividend?

The last dividend was paid out on 9/27/2024.

What was the dividend of Champions Oncology in the year 2023?

In the year 2023, Champions Oncology distributed 0 USD as dividends.

In which currency does Champions Oncology pay out the dividend?

The dividends of Champions Oncology are distributed in USD.